These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33256620)
1. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation. Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620 [TBL] [Abstract][Full Text] [Related]
2. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report. Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596 [TBL] [Abstract][Full Text] [Related]
4. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413 [TBL] [Abstract][Full Text] [Related]
5. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice. Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993 [TBL] [Abstract][Full Text] [Related]
6. ABCB4 disease: Many faces of one gene deficiency. Sticova E; Jirsa M Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867 [TBL] [Abstract][Full Text] [Related]
7. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report. Wu Z; Zhang S; Zhang L; Li M Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Novel Missense Mutation in Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542 [TBL] [Abstract][Full Text] [Related]
9. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4 Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584 [TBL] [Abstract][Full Text] [Related]
10. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum. Reichert MC; Lammert F Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767 [TBL] [Abstract][Full Text] [Related]
11. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3. Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905 [TBL] [Abstract][Full Text] [Related]
12. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature. Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319 [TBL] [Abstract][Full Text] [Related]
14. ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall. Sticova E; Neroldova M; Kotalova R; Subhanova I; Jirsa M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):121-125. PubMed ID: 31728073 [TBL] [Abstract][Full Text] [Related]
15. Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion. Tsuruya K; Yokoyama K; Mishima Y; Ida K; Araki T; Ieda S; Ohtsuka M; Inagaki Y; Honda A; Kagawa T; Kamiya A J Lipid Res; 2024 Sep; 65(9):100616. PubMed ID: 39111549 [TBL] [Abstract][Full Text] [Related]
16. Paucity of Interlobular Bile Ducts in Multidrug-Resistant P-Glycoprotein 3 (MDR3) Deficiency. Vij M; Valamparampil J; Shanmugum N; Reddy SM; Rajindrajith S; Rela M Int J Surg Pathol; 2019 May; 27(3):343-347. PubMed ID: 30222019 [TBL] [Abstract][Full Text] [Related]
17. Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of Zhu H; Wang S; Li L; Geng W; Wan X; Hua R; Wang D; Gao P Front Pediatr; 2022; 10():1012825. PubMed ID: 36330364 [TBL] [Abstract][Full Text] [Related]
18. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine. Prescher M; Kroll T; Schmitt L Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833 [TBL] [Abstract][Full Text] [Related]
19. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis. Küçükçongar Yavaş A; Çavdarlı B; Ünal Uzun Ö; Uncuoğlu A; Gündüz M J Pediatr Endocrinol Metab; 2020 May; 33(5):665-669. PubMed ID: 32229667 [TBL] [Abstract][Full Text] [Related]
20. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature. Delaunay JL; Durand-Schneider AM; Delautier D; Rada A; Gautherot J; Jacquemin E; Aït-Slimane T; Maurice M Hepatology; 2009 Apr; 49(4):1218-27. PubMed ID: 19185004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]